Hayashi Masahiro, Higashi Kotaro, Kobayashi Katsuji
Neurology and Psychiatry, Medical Corporation Asanokawa, Sakuragaoka Hospital, Kanazawa, JPN.
Radiology, Medical Corporation Asanokawa, Asanokawa General Hospital, Kanazawa, JPN.
Cureus. 2024 Aug 8;16(8):e66475. doi: 10.7759/cureus.66475. eCollection 2024 Aug.
Cerebral amyloid angiopathy-related inflammation (CAA-ri) is a rare condition primarily driven by an autoimmune reaction against cerebrovascular amyloid beta protein. Accurate diagnosis hinges on recognizing characteristic clinical symptoms and imaging features, such as asymmetric cerebral white matter lesions often linked to angioedema. We report the case of a woman in her 70s with progressive, irreversible CAA-ri who initially presented with left homonymous hemianopia and experienced significant psychiatric and neurological deterioration following an epileptic seizure. Despite initiating corticosteroid therapy seven months after onset, her condition continued to worsen, ultimately leading to her death in the 11th month due to general decline. This report reviews the clinical progression and imaging findings of the case, discusses the diagnostic process for CAA-ri, differentiates it from related conditions, and evaluates the timing of corticosteroid treatment.
脑淀粉样血管病相关炎症(CAA-ri)是一种罕见疾病,主要由针对脑血管淀粉样β蛋白的自身免疫反应驱动。准确诊断取决于识别特征性临床症状和影像学特征,如常与血管性水肿相关的不对称性脑白质病变。我们报告了一例70多岁患有进行性、不可逆CAA-ri的女性病例,她最初表现为左侧同向性偏盲,癫痫发作后出现明显的精神和神经功能恶化。尽管在发病七个月后开始使用皮质类固醇治疗,但其病情仍持续恶化,最终在第11个月因全身状况恶化而死亡。本报告回顾了该病例的临床进展和影像学表现,讨论了CAA-ri的诊断过程,将其与相关疾病进行了鉴别,并评估了皮质类固醇治疗的时机。